2017 American Transplant Congress
Influence of Donor-Specific Antibodies on Renal Function in Kidney Transplant Recipients Following Early Switch from Calcineurin Inhibitor to Everolimus: Subanalysis from the ELEVATE Study.
1ELEVATE Study Group, Llobregat Catalunya, Spain; 2Novartis Pharma AG, Basel, Switzerland
Purpose: The development of donor-specific antibody (DSA) is a known risk factor for poor graft outcomes after kidney transplantation (KTx). Previous analysis of the ELEVATE…2017 American Transplant Congress
A Single Skin Commensal Strain Is Sufficient to Accelerate Skin Transplant Rejection.
The kinetics of graft rejection depend mostly on the extent of genetic disparities between organ donor and recipient, but appreciation that environmental factors may also…2017 American Transplant Congress
HCC and Liver Transplantation Following the Recent Allocation Policy Change.
Johns Hopkins University, Baltimore
In October 2015, OPTN implemented a revised liver allocation policy to address the disparity between HCC and non-HCC patients in access to deceased-donor liver transplant…2017 American Transplant Congress
Young African American Heart Transplant Recipients Have an Elevated Risk of Post-Transplant Mortality.
African American (AA) race is associated with worse survival among heart transplant recipients. Even after controlling for socioeconomic and clinical characteristics, racial disparities persist and…2017 American Transplant Congress
Resumption of Standard Dose Immunosuppression Following Resolution of BK Viremia Does Not Lead to Viremia Recurrence.
Medicine, Nephrology, University of Florida, Gainesville, FL
Introduction: Reduction of immunosuppression (IS) in response to BK viremia following kidney transplantation prevents the development of BK virus nephropathy, with no apparent increase in…2017 American Transplant Congress
Clinical Evaluation of the Safety and Preliminary Efficacy of Continuous Infusion of Treprostinil to Prevent Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplant Recipients.
Introduction:Liver transplantation is currently the only therapeutic option for patients with end stage liver diseases. Liver allografts undergo cold ischemic injury and warm reperfusion injury…
